The conditions that shape us: the UAE and GCC exposome, environmental health and competitiveness
Rooted in the desert resilience of the Ghaf, we read the environments, systems and exposures that meet health and national competitiveness across the UAE and GCC, and ask what a credible future of preventive health requires.
Explore the Exposome ConstellationChoose your way in
- For researchersFind the studies and their limitsRegional studies, measured variables and stated limitations, in one library.
- For policymakersRead the systems behind the signalsHeat, air, water and policy questions mapped without overstating what is known.
- For curious readersBegin with the idea itselfA plain-language guide to the exposome and why place matters to health.
Evidence first. Questions forward.
Founding editor
Dr Maryam Matar
Founder of the UAE Genetic Diseases Association, with documented work across public policy, genetic-disease prevention, regional science cooperation and epigenetics outreach. Roles are described as reported in each source and with their dates.
- Public policy
- Genetic testing
- Geopolicy & science cooperation
- Epigenetics & exposome
Exposome Constellation
Six conceptual plates on women’s health, cosmetics, endocrine-disrupting chemicals and personal hygiene products.
- 01 The exposome
- 02 Women’s health
- 03 Cosmetics
- 04 Endocrine-disrupting chemicals
- 05 Personal hygiene products
- 06 The UAE & GCC perspective
You / Genome
01The exposomeA lifetime of environments
The exposome considers exposures across life—not only the genes we inherit.
Takeaway. Many sources. Multiple pathways. Changing exposure over time.
- AirWhat we breathe
- Diet & waterWhat we consume
- ProductsWhat contacts our skin
- Living conditionsWhere we live and work
Evidence boundary
This is a conceptual map, not a measured UAE exposure profile or personal health score.
Sources
02Women’s healthTiming matters
Hormones help regulate development, fertility and reproduction. Exposure timing is part of the research question.
Takeaway. NIEHS describes research linking certain phthalate exposures with reproductive and developmental outcomes.
- Early lifeDevelopmental context
- PubertyHormonal transitions
- Reproductive yearsFertility research
- PregnancyMaternal and fetal health
Evidence boundary
Associations differ by chemical, timing and study. They do not predict an individual woman’s outcome or establish UAE prevalence.
Sources
03CosmeticsBeyond the beauty label
Formulations, ingredients and how a product is used matter more than a blanket “safe” or “toxic” label.
Takeaway. NIEHS studies ingredients and product-use patterns; finding a chemical does not by itself prove harm.
- FragranceDEP may act as a solvent or fixative
- PreservativesSome formulations use parabens
- Skin contactOne potential exposure pathway
- SpraysAirborne contact can also matter
Evidence boundary
FDA reports no current safety concerns for DEP as used in cosmetics and fragrances. This U.S. assessment is not a statement of UAE regulation.
Sources
04Endocrine-disrupting chemicalsWhen chemical signals interfere
Some chemicals may mimic, block or interfere with the body’s hormones.
Takeaway. NIEHS identifies phthalates, BPA and several other chemical groups as areas of endocrine research.
- MimicResemble a hormone signal
- BlockInterfere with a signal
- AlterChange hormone activity or levels
- InvestigateIdentify the specific chemical and context
Evidence boundary
Not every member of a chemical group has the same evidence or effect. A hazard description is not a diagnosis or proof that a particular product causes disease.
Sources
05Personal hygiene productsEveryday routines, different exposures
Cleansers, shampoos, lotions and scented products can contribute to the wider exposure picture.
Takeaway. Consider the formulation, use pattern and relevant evidence—not just the product category.
- CleanseSoap, body wash and shampoo
- ApplyLotions and other leave-on products
- ReadIngredients and use instructions
- AskWhat evidence applies to this product?
Evidence boundary
These illustrations do not recommend abandoning hygiene, prescribed care or sun protection. “Natural” and “chemical-free” are not scientific guarantees of safety.
Sources
06The UAE & GCC perspectiveFrom questions to evidence
For women’s exposome research in the Gulf, local exposure measurements and context would be essential.
Takeaway. A proposed research agenda: combine life-course context, product use and environmental measurements.
- DefineWhich products, people and time window?
- MeasureActual exposure—not assumptions
- InterpretSeparate association from causation
- ValidateTest findings in relevant populations
Evidence boundary
This is the platform’s interpretation and proposed agenda. International findings are not evidence of measured UAE/GCC risks, and this conceptual map is not medical advice.
Sources
Conceptual map, not a measured UAE exposure profile or personal health score. Each plate states what its evidence cannot say.
Read all six plates as text
01 · The exposome
A lifetime of environments
The exposome considers exposures across life—not only the genes we inherit.
- Air: What we breathe
- Diet & water: What we consume
- Products: What contacts our skin
- Living conditions: Where we live and work
Takeaway. Many sources. Multiple pathways. Changing exposure over time.
Evidence boundary. This is a conceptual map, not a measured UAE exposure profile or personal health score.
Sources: Wild · exposome framework (2005) (opens in a new tab); NIEHS · Endocrine Disruptors (reviewed March 2026) (opens in a new tab)
02 · Women’s health
Timing matters
Hormones help regulate development, fertility and reproduction. Exposure timing is part of the research question.
- Early life: Developmental context
- Puberty: Hormonal transitions
- Reproductive years: Fertility research
- Pregnancy: Maternal and fetal health
Takeaway. NIEHS describes research linking certain phthalate exposures with reproductive and developmental outcomes.
Evidence boundary. Associations differ by chemical, timing and study. They do not predict an individual woman’s outcome or establish UAE prevalence.
Sources: NIEHS · Endocrine Disruptors (reviewed March 2026) (opens in a new tab); NIEHS · Cosmetics and Your Health (January 2024) (opens in a new tab)
03 · Cosmetics
Beyond the beauty label
Formulations, ingredients and how a product is used matter more than a blanket “safe” or “toxic” label.
- Fragrance: DEP may act as a solvent or fixative
- Preservatives: Some formulations use parabens
- Skin contact: One potential exposure pathway
- Sprays: Airborne contact can also matter
Takeaway. NIEHS studies ingredients and product-use patterns; finding a chemical does not by itself prove harm.
Evidence boundary. FDA reports no current safety concerns for DEP as used in cosmetics and fragrances. This U.S. assessment is not a statement of UAE regulation.
Sources: NIEHS · Cosmetics and Your Health (January 2024) (opens in a new tab); FDA · Phthalates in Cosmetics (opens in a new tab); NIEHS · Endocrine Disruptors (reviewed March 2026) (opens in a new tab)
04 · Endocrine-disrupting chemicals
When chemical signals interfere
Some chemicals may mimic, block or interfere with the body’s hormones.
- Mimic: Resemble a hormone signal
- Block: Interfere with a signal
- Alter: Change hormone activity or levels
- Investigate: Identify the specific chemical and context
Takeaway. NIEHS identifies phthalates, BPA and several other chemical groups as areas of endocrine research.
Evidence boundary. Not every member of a chemical group has the same evidence or effect. A hazard description is not a diagnosis or proof that a particular product causes disease.
Sources: NIEHS · Endocrine Disruptors (reviewed March 2026) (opens in a new tab); FDA · Phthalates in Cosmetics (opens in a new tab)
05 · Personal hygiene products
Everyday routines, different exposures
Cleansers, shampoos, lotions and scented products can contribute to the wider exposure picture.
- Cleanse: Soap, body wash and shampoo
- Apply: Lotions and other leave-on products
- Read: Ingredients and use instructions
- Ask: What evidence applies to this product?
Takeaway. Consider the formulation, use pattern and relevant evidence—not just the product category.
Evidence boundary. These illustrations do not recommend abandoning hygiene, prescribed care or sun protection. “Natural” and “chemical-free” are not scientific guarantees of safety.
Sources: NIEHS · Cosmetics and Your Health (January 2024) (opens in a new tab); FDA · Phthalates in Cosmetics (opens in a new tab); NIEHS · Endocrine Disruptors (reviewed March 2026) (opens in a new tab)
06 · The UAE & GCC perspective
From questions to evidence
For women’s exposome research in the Gulf, local exposure measurements and context would be essential.
- Define: Which products, people and time window?
- Measure: Actual exposure—not assumptions
- Interpret: Separate association from causation
- Validate: Test findings in relevant populations
Takeaway. A proposed research agenda: combine life-course context, product use and environmental measurements.
Evidence boundary. This is the platform’s interpretation and proposed agenda. International findings are not evidence of measured UAE/GCC risks, and this conceptual map is not medical advice.
Sources: Wild · exposome framework (2005) (opens in a new tab); NIEHS · Cosmetics and Your Health (January 2024) (opens in a new tab); NIEHS · Endocrine Disruptors (reviewed March 2026) (opens in a new tab)
Live from public sources
Exposome news & publications
International context, retrieved automatically. Publication dates are shown exactly as supplied; older items stay visible.
- Editorial updateExposome UAE
New branch: Future Medicine & Science
- Editorial updateExposome UAE
Two new essays explore the exposome, epigenetics and optogenetics
Automatically retrieved from NIEHS (opens in a new tab) and Europe PMC (opens in a new tab). International context, not measured UAE/GCC evidence; retrieval is not editorial or clinical review.
Publication entries are index records. Their inclusion does not indicate peer review or endorsement.
Evidence base
Sources we draw on
Published sources we cite, not partners or endorsers.
- View cited sources: NIEHS, February 2025
- View cited sources: WHO heat fact sheet, 31 July 2026
- View cited sources: NCM National Air Quality Platform
- View cited sources: NHGRI, Epigenomics fact sheet
- View cited sources: UNESCO Memory of the World, Huang Di Nei Jing
- View cited sources: GCC Secretary General, 25 Sep 2026
A wider view of the world around health.
Environmental
Air, water, heat and the places we inhabit.
Social
Work, mobility, access and the conditions of daily life.
Chemical & physical
The measurable exposures and physical forces in our surroundings.
Geopolitical
Regional systems and policy contexts that shape shared conditions.
Ideas travel through time. Evidence has its own chronology.
From ancient health perspectives to a 2005 scientific framework: a careful timeline, without rewriting history.
Clarity about what we know.
Cited
Primary sources and references close to the claims they support.
Bounded
Policy statements, historical accounts and independent evidence stay distinct.
Open
We show uncertainty and gaps rather than filling them with invented certainty.